mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.006 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.007 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.007 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.008 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.009 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |